October 15, 2021

Dr. Harvey Risch is a practicing epidemiologist with more than 40 years of experience researching the etiology of cancer, including pancreas, ovarian and other cancers. He holds an academic appointment as Professor of Epidemiology at the Yale School of Public Health, Yale School of Medicine, and Yale Cancer Center. Dr. Risch received his Bachelor of Science in mathematics and biology from the California Institute of Technology in 1972 and completed medical training at UC San Diego School of Medicine in 1976. He completed a PhD in biomathematics in 1980 at the University of Chicago, focused on quantitative solutions for the general stochastic epidemic model. Dr. Risch has published more than 350 peer-reviewed original research papers in well-regarded scientific journals and has an h-index of 94, with more than 43,000 publication citations to-date.

Dr. Risch has served as peer reviewer for more than 50 scientific and medical journals.  He has been Associate Editor of the Journal of the National Cancer Institute since 2000, Editor pro tem of the American Journal of Epidemiology from 2002-2014 and member of the Board of Editors of this journal from 2014-2020, and Editor of the International Journal of Cancer since 2008. In May 2020, Dr. Risch published the seminal paper on early treatment of high-risk COVID-19 outpatients in the American Journal of Epidemiology, which has been downloaded 88,000 times and viewed by more than 130,000.  Dr. Risch was senior author on a groundbreaking outpatient clinical trial study in Brazil, and has co-authored two papers [1, 2] that form the now-standard understanding of early outpatient COVID-19 management. Dr. Risch gave testimony about early COVID-19 treatment before the U.S. Senate in November 2020.

As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.

Here is his website https://earlycovidcare.org/our-expert/ – read it for yourself.